NIBEC Co., Ltd. announced that it expects to receive KRW 10 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, DB Financial Investment Co.,Ltd., Investment Arm
December 22, 2020
Share
NIBEC Co., Ltd. (KOSDAQ:A138610) announced a private placement of round 6 non-guaranteed private convertible bonds with bearer interest for gross proceeds of KRW 10,000,000,000 on December 23, 2020. The bonds are zero coupon bonds and will mature on December 28, 2025. The bonds are 100% convertible into 245,212 common shares at a conversion price of KRW 40,781 per share. The conversion period of the bonds starts on December 28, 2021 and ends on November 28, 2025. The transaction will include participation from Mirae Asset Daewoo Co., Ltd., Investment Arm for KRW 2,000,000,000, DB Financial Investment Co.,Ltd., Investment Arm for KRW 1,000,000,000, funds managed by, NH Investment & Securities Co., Ltd., Investment Arm for KRW 1,000,000,000, Samsung Securities Co. Ltd., Investment Arm for KRW 2,000,000,000, KB Securities Co., Ltd., Investment Arm for KRW 2,000,000,000 and Korea Investment & Securities Co., Ltd., Investment Arm for KRW 2,000,000,000. The transaction has been approved by the board of directors of the company. The subscription date and payment date of the transaction is December 28, 2020. The bonds are subject to conversion for one year from the date of issue of bonds and prohibition of splitting and merging of recommendations.
NIBEC Co., Ltd. is a Korea-based company specialized in the manufacturing of dental medical products and supplies. The Company provides two main categories of products: dental health products and regeneration biomaterials. The dental health products consist of tooth whitening products under the brand name Blanc Tis; remedies for sensitive teeth under the brand name SensBlok, and dental conditioners under the brand name Clinplant. The regeneration biomaterials include bone graft materials under the brand name OCS-B, OCS-H and OCS-Collagen, as well as bone regenerative powders, bone morphogenetic materials, peptide bone powders and injectable gels. It also provides cosmetics under the brand name Skin Aropa. The Company distributes its products within domestic market and to overseas markets.